PMID- 29704511 OWN - NLM STAT- MEDLINE DCOM- 20180604 LR - 20220331 IS - 1872-7786 (Electronic) IS - 0009-2797 (Linking) VI - 289 DP - 2018 Jun 1 TI - NGAL attenuates renal ischemia/reperfusion injury through autophagy activation and apoptosis inhibition in rats. PG - 40-46 LID - S0009-2797(17)30396-4 [pii] LID - 10.1016/j.cbi.2018.04.018 [doi] AB - Ischemia/reperfusion (I/R) injury is a main cause of acute kidney injury (AKI), and currently lacks effective therapies. This study is to investigate the level of Neutrophil gelatinase-associated lipocalin (NGAL) and autophagy status during renal I/R injury, so as to determine whether the exogenous NGAL protein could exert a protective effect for I/R injury and explore the potential mechanisms. Forty male Wistar rats were randomly divided into the following four groups: Sham, I/R, pre-treated with NGAL before I/R (I/R + pre-N), treated with NGAL after I/R (I/R + post-N). All rats were subjected to clamping the left renal pedicle for 45 min after right nephrectomy, followed by 24 h of reperfusion. Serum creatinine (SCr) and blood urea nitrogen (BUN) were used for renal function, tubular cell apoptosis and autophagy were measured by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) method, histological examination and electron microscope, respectively. The tubular cell proliferation was assessed by the protein expression of proliferating cell nuclear antigen (PCNA). Western blotting was used to quantitate the levels of LC3, Beclin-1, Bcl-2 and Bax in kidney tissues. Exogenous NGAL protein intervention significantly improved renal function, reduced tubular cell apoptosis, increased tubular cell proliferation and promoted autophagy activation after renal I/R injury. Further, the efficacy in pre-N was significantly better than post-N. The mechanisms were involved in the regulation of several autophagy and apoptosis-related genes. Our study demonstrated that exogenous NGAL protein play a protective role during I/R injury, which may offer a novel may for prevention and treatment of renal I/R injury. CI - Copyright (c) 2018. Published by Elsevier B.V. FAU - Zhang, Ya-Li AU - Zhang YL AD - Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. FAU - Qiao, Shu-Kai AU - Qiao SK AD - Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. FAU - Wang, Rong-Ying AU - Wang RY AD - Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. Electronic address: wangrongying2017@sina.com. FAU - Guo, Xiao-Nan AU - Guo XN AD - Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. LA - eng PT - Journal Article DEP - 20180425 PL - Ireland TA - Chem Biol Interact JT - Chemico-biological interactions JID - 0227276 RN - 0 (Lipocalin-2) RN - 0 (Proliferating Cell Nuclear Antigen) RN - AYI8EX34EU (Creatinine) SB - IM MH - Animals MH - *Apoptosis MH - *Autophagy MH - Blood Urea Nitrogen MH - Cell Proliferation MH - Creatinine/blood MH - Epithelium/metabolism/pathology MH - In Situ Nick-End Labeling MH - Kidney Function Tests MH - Kidney Tubules/metabolism/pathology MH - Lipocalin-2/*metabolism MH - Male MH - Proliferating Cell Nuclear Antigen/metabolism MH - Rats, Wistar MH - Reperfusion Injury/*metabolism/*pathology/physiopathology MH - Vacuoles/metabolism/ultrastructure OTO - NOTNLM OT - Apoptosis OT - Autophagy OT - Ischemia-reperfusion OT - Neutrophil gelatinase-associated lipocalin OT - Proliferation EDAT- 2018/04/29 06:00 MHDA- 2018/06/05 06:00 CRDT- 2018/04/29 06:00 PHST- 2017/04/21 00:00 [received] PHST- 2018/04/11 00:00 [revised] PHST- 2018/04/13 00:00 [accepted] PHST- 2018/04/29 06:00 [pubmed] PHST- 2018/06/05 06:00 [medline] PHST- 2018/04/29 06:00 [entrez] AID - S0009-2797(17)30396-4 [pii] AID - 10.1016/j.cbi.2018.04.018 [doi] PST - ppublish SO - Chem Biol Interact. 2018 Jun 1;289:40-46. doi: 10.1016/j.cbi.2018.04.018. Epub 2018 Apr 25.